Estimating Standard Errors in Finance Panel Data Sets: Comparing Approaches [PDF]
In both corporate finance and asset pricing empirical work, researchers are often confronted with panel data. In these data sets, the residuals may be correlated across firms and across time, and OLS standard errors can be biased.
Mitchell A. Petersen
core
Fast standard error estimation for joint models of longitudinal and time-to-event data based on stochastic EM algorithms. [PDF]
Yu T, Wu L, Bosch RJ, Smith DM, Wang R.
europepmc +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Reporting the standard error of the mean: a critical analysis of three journals in manual medicine. [PDF]
Manovic A +3 more
europepmc +1 more source
An Improvement in Estimation of the Standard Error for the Natural Direct Effect in Causal Mediation Analysis. [PDF]
Gao X, Luo L.
europepmc +1 more source
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park +6 more
wiley +1 more source
Exploring Methodological Decisions for Calculating the Minimally Detectable Change in Dysarthria: Reliability, Statistics, and Standard Error of Measurement. [PDF]
Gates KE, Mefferd AS, Stipancic KL.
europepmc +1 more source
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
The FeetMe<sup>®</sup> Insoles System: Repeatability, Standard Error of Measure, and Responsiveness. [PDF]
Martin N, Leboeuf F, Pradon D.
europepmc +1 more source

